Triumph Gold Updates Shareholders on Operations, Engages Market Maker, and Grants Options
May 11, 2025
Investing
Reviews 2025 exploration strategy across Freegold Mountain and Andalusite Peak Advances acquisition strategy targeting high-grade silver assets Engages Independent Trading…
Three Charts to Watch for an “All Clear” Signal
May 10, 2025
Stock
With all eyes and ears on this week’s Fed meeting, it’s worth taking a big step back to reflect on…
Use This Multi-Timeframe MACD Signal for Precision Trades
May 10, 2025
Stock
In this video, Joe shares how to trade MACD signals using multiple timeframes, and how to spot stock market pullback…
The Unpredictable Stock Market: How to Make Sense of It
May 10, 2025
Stock
The stock market’s action on Wednesday was a bit like trying to pick a dinner spot with friends—lots of back…
Don’t Buy Robinhood Stock… Until You See This Chart Setup
May 10, 2025
Stock
Robinhood Markets, Inc. (HOOD) is back in the spotlight, wrestling with its four-year highs and turning heads on Wall Street.…
The V Reversal is Impressive, but is it Enough?
May 10, 2025
Stock
Stocks plunged into early April and surged into early May, suggesting that a “V” reversal is in the making. There…
Drill Contract Awarded for Elizabeth Hill. Technical Visit Completed to Define Drill Targets
May 10, 2025
Investing
Errawarra Resources Ltd (ASX: ERW) is pleased to advise that it has awarded its inaugural drilling contract at the high-grade…
$2.6M Placement and SPP to fast-track China entry and sales
May 10, 2025
Investing
Wide Open Agriculture (WOA:AU) has announced $2.6M Placement and SPP to fast-track China entry and sales Download the PDF here.…
NorthStar Gaming Announces Receipt of Management Cease Trade Order
May 10, 2025
Investing
NorthStar Gaming Holdings Inc. (TSXV: BET) (OTCQB: NSBBF) (‘NorthStar’ or the ‘Company’) today announces that its principal regulator, the Ontario…
US Policy Momentum, Clinical Progress Fueling Psychedelics Market in 2025
May 10, 2025
Investing
When the US Food and Drug Administration (FDA) rejected Lykos Therapeutics’ new drug application for MDMA-assisted therapy last August, the…